University nanotechnology patents : China, USA and Korea most productive countries


This chart was built by searching the Espacenet database for patents

1) mentionning the prefix “nano” in their title or abstract

2) mentionning “univ” and the country code in the “applicant” field

3) without any restriction of publication year

Only the top 10 most visible countries according to these criteria are presented in the chart.

USA risk losing global leadership in nanotech


According to a new report from Lux Research, “In terms of sheer volume, The U.S. dominated the rest of the world in nanotech funding and new patents last year (…). But (…) countries such as China and Russia launched new challenges to U.S. dominance in 2009, while smaller players such as Japan, Germany and South Korea surpassed the United States in terms of commercializing nanotechnology and products.” (press release)

 [[[ Additional links suggested by Nanocolors :

Has China already passed America in nanotechnology?

Nano-related patents – the most visible countries 

Ranking the nations on nanotech ]]]

New phase I clinical trial involving a polymeric nanoparticle formulation of docetaxel


Korean company Samyang started in April 2010 a phase I clinical trial involving a polymeric nanoparticle formulation of docetaxel, now registered in the Clinicaltrials.gov database under reference NCT01103791. According to this page, the aim is to “determine the maximum tolerated dose and recommended phase II dose of docetaxel-PNP (polymeric nanoparticle formulation of docetaxel) and to evaluate the safety and pharmacokinetics of docetaxel-PNP in subjects with advanced solid malignancies“.

Nano Korea 2009


The 2009 Nano Korea Exhibition will take place in Korea’s Kintex in Seoul from August 26th till August 28th. The main exhibit categories already advertised are nanodevices, nanomaterials, nanomanufacturing, nano evaluation & measurement, and applications.  The Nano Korea Symposium and Microtechworld events will take place at the same time and same venue.